| Thomas E Lyons, DPM | |
|
185 Pilgrim Rd, Division Of Podiatry, Boston, MA 02215-5324 | |
| (617) 632-7082 | |
| (617) 632-7085 |
| Full Name | Thomas E Lyons |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 37 Years |
| Location | 185 Pilgrim Rd, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841239878 | NPI | - | NPPES |
| 0357855 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 1955 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Shore Hospital | South weymouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Medical Associates | 7113029257 | 412 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that providers associated with Austin, Texas, Seton Healthcare Family have each received an $18,000 check from the Centers of Medicare & Medicaid Services (CMS) after successfully attesting for meaningful use, the maximum amount allowed for 2011.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 3 days ago
| Provider Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720037385 PECOS PAC ID: 4486567104 Enrollment ID: O20031203000426 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that providers associated with Austin, Texas, Seton Healthcare Family have each received an $18,000 check from the Centers of Medicare & Medicaid Services (CMS) after successfully attesting for meaningful use, the maximum amount allowed for 2011.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 3 days ago
| Provider Name | South Shore Medical Center, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669411856 PECOS PAC ID: 3678487444 Enrollment ID: O20040413000332 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that providers associated with Austin, Texas, Seton Healthcare Family have each received an $18,000 check from the Centers of Medicare & Medicaid Services (CMS) after successfully attesting for meaningful use, the maximum amount allowed for 2011.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 3 days ago
| Provider Name | Beth Israel Deaconess Medical Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that providers associated with Austin, Texas, Seton Healthcare Family have each received an $18,000 check from the Centers of Medicare & Medicaid Services (CMS) after successfully attesting for meaningful use, the maximum amount allowed for 2011.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 3 days ago
| Provider Name | Coastal Medical Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932175684 PECOS PAC ID: 7113029257 Enrollment ID: O20070221000057 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that providers associated with Austin, Texas, Seton Healthcare Family have each received an $18,000 check from the Centers of Medicare & Medicaid Services (CMS) after successfully attesting for meaningful use, the maximum amount allowed for 2011.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas E Lyons, DPM 185 Pilgrim Rd, Division Of Podiatry, Boston, MA 02215-5324 Ph: (617) 632-7082 | Thomas E Lyons, DPM 185 Pilgrim Rd, Division Of Podiatry, Boston, MA 02215-5324 Ph: (617) 632-7082 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that providers associated with Austin, Texas, Seton Healthcare Family have each received an $18,000 check from the Centers of Medicare & Medicaid Services (CMS) after successfully attesting for meaningful use, the maximum amount allowed for 2011.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 3 days ago
John M Giurini, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 185 Pilgrim Rd, Division Of Podiatry, Boston, MA 02215 Phone: 617-632-7071 Fax: 617-632-7085 | |
Dr. Jordana Lea Szpiro, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 264 Beacon St, 4th Floor, Boston, MA 02116 Phone: 617-262-2266 Fax: 617-262-2261 | |
Dr. Eric E Schultz, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 332 Hanover St, Boston, MA 02113 Phone: 617-643-8100 | |
Dr. James P Ioli, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 75 Francis St, Dept Of Orthopeodic Surgery, Boston, MA 02115 Phone: 617-732-5391 Fax: 617-264-6305 | |
Richard Vallon, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 750 Washington St, Boston, MA 02111 Phone: 617-636-5269 | |
Dr. Raymond Salvatore Murano Iii, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 185 Pilgrim Rd, Baker Building 3rd Floor, Boston, MA 02215 Phone: 617-632-8428 | |
Ramiro J Manzano, MD Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1153 Centre St, Suite 5980, Boston, MA 02130 Phone: 617-983-1900 Fax: 617-983-8122 |